Log In | Register
NEW YORK — Par Pharmaceutical Cos. said Friday it is selling up to $150 million in a mixed shelf offering and plans to use the proceeds for general corporate purposes.
The company is offering common stock, preferred stock, debt securities and warrants, according to a Securities and Exchange Commission filing.
Shares of Woodcliff Lake, N.J.-based Par Pharmaceutical fell 14 cents to close at $14.33.
© 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
